[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,910,081
  • Shares Outstanding, K 38,160
  • Annual Sales, $ 0 K
  • Annual Income, $ -212,180 K
  • EBIT $ -266 M
  • EBITDA $ -274 M
  • 60-Month Beta 0.97
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.23

Options Overview Details

View History
  • Implied Volatility 50.27% (+3.33%)
  • Historical Volatility 41.18%
  • IV Percentile 21%
  • IV Rank 10.36%
  • IV High 131.40% on 01/20/26
  • IV Low 40.89% on 09/12/25
  • Expected Move (DTE 13) 2.99 (3.92%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 138
  • Volume Avg (30-Day) 584
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 4,526
  • Open Int (30-Day) 4,666
  • Expected Range 73.27 to 79.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.58
  • Number of Estimates 5
  • High Estimate $-1.37
  • Low Estimate $-1.76
  • Prior Year $-1.58
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
64.67 +17.92%
on 06/08/26
76.67 -0.53%
on 07/02/26
+8.26 (+12.15%)
since 06/02/26
3-Month
63.79 +19.55%
on 05/19/26
76.67 -0.53%
on 07/02/26
+11.08 (+17.00%)
since 04/02/26
52-Week
40.00 +90.65%
on 02/13/26
99.50 -23.36%
on 12/08/25
+23.09 (+43.43%)
since 07/02/25

Most Recent Stories

More News
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , June 29, 2026 /PRNewswire/ --

IRON : 76.26 (+1.75%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , June 24, 2026 /PRNewswire/ --

IRON : 76.26 (+1.75%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , June 19, 2026 /PRNewswire/ --

IRON : 76.26 (+1.75%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , June 14, 2026 /PRNewswire/ --

IRON : 76.26 (+1.75%)
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

Data from the RALLY-MF trial of DISC-0974 in patients with myelofibrosis (MF) and anemia demonstrate meaningful, durable overall anemia responses across all patient subgroups, regardless of baseline transfusion...

IRON : 76.26 (+1.75%)
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response and could potentially support a traditional approval On track for expected CRL response submission...

IRON : 76.26 (+1.75%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , June 8, 2026 /PRNewswire/ --

IRON : 76.26 (+1.75%)
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON

NEW YORK , June 3, 2026 /PRNewswire/ --

IRON : 76.26 (+1.75%)
Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Demonstrated meaningful, durable overall anemia responses across all patient subgroups, regardless of baseline transfusion status  Anemia response was seen independent of concomitant JAK inhibitor...

IRON : 76.26 (+1.75%)
Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

The expanded access program (EAP) is available to eligible patients with erythropoietic protoporphyria (EPP) and provides access to bitopertin prior to regulatory decision Bitopertin, an oral glycine...

IRON : 76.26 (+1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Disc Medicine Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases. Disc Medicine Inc., formerly known as Gemini Therapeutics Inc., is based in WAYLAND, Mass.

See More

Key Turning Points

3rd Resistance Point 80.09
2nd Resistance Point 78.38
1st Resistance Point 77.32
Last Price 76.26
1st Support Level 74.55
2nd Support Level 72.84
3rd Support Level 71.78

See More

52-Week High 99.50
Fibonacci 61.8% 76.77
Last Price 76.26
Fibonacci 50% 69.75
Fibonacci 38.2% 62.73
52-Week Low 40.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.